Switching to biosimilars could save £1bn over five years, says NHS England

To facilitate cost savings, NHS England is considering making it a new service condition that NHS providers ensure the best-value biosimilar medicines are prescribed.
Medicines on a production line

Switching from original biologic to biosimilar medicines could save the NHS £1bn over five years, NHS England has told The Pharmaceutical Journal.

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Last updated